Evidence map›Paper›PMID 33298996›Full record

ArticleScientific reports2020

The variability of functional MRI brain signal increases in Alzheimer's disease at cardiorespiratory frequencies.

Timo Tuovinen, Janne Kananen, Zalan Rajna, Johannes Lieslehto, Vesa Korhonen, Riikka Rytty, Heli Mattila, Niko Huotari, Lauri Raitamaa, Heta Helakari and 8 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Infra-slow (<0.1 Hz) Modulation of Human Brain Pulsations in Awake and Sleep States.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Orexin effect on physiological pulsations of the human brain.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Timo TuovinenOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland. timo.tuovinen@oulu.fi.
Janne KananenOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Zalan RajnaOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Johannes LieslehtoCenter for Life Course Health Research, University of Oulu, Oulu, Finland.
Vesa KorhonenOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Riikka RyttyOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Heli MattilaOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Niko HuotariOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Lauri RaitamaaOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Heta HelakariOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Ahmed Abou ElseoudDepartment of Diagnostic Radiology, Helsinki University Hospital, Helsinki, Finland.
Johanna KrügerMedical Research Center, Oulu University Hospital, Oulu, Finland.
Pierre LeVanDepartment of Radiology, Medical Physics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Osmo TervonenOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.
Juergen HennigDepartment of Radiology, Medical Physics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Anne M RemesMedical Research Center, Oulu University Hospital, Oulu, Finland.
Maiken NedergaardCenter for Translational Neuromedicine, University of Rochester Medical Center, Rochester, NY, USA.
Vesa KiviniemiOulu Functional Neuroimaging, Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland. vesa.kiviniemi@oulu.fi.
University of Oulu · FIOulu University Hospital · FIHelsinki University Hospital · FIUniversity of Calgary · CAUniversity of Freiburg · DEUniversity of Rochester Medical Center · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Para-Vascular Basis of Small Vessel DiseaseR01NS100366 · NINDS · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN · 2016 to 2020
$3.8M
Age and AD related bottlenecks in glymphatic-lymphatic waste transportRF1AG057575 · NIA · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN · 2017 to 2017
$3.2M
Capillary hyperemia in white matter: Novel mechanistic insight and effect of hypertension and agingRF1NS110049 · NINDS · UNIVERSITY OF ROCHESTER · PI NEDERGAARD, MAIKEN, WAN, JIANDI · 2018 to 2018
$2.9M
CIHRNIA NIH HHS RF1 AG057575NIA NIH HHS U01 AG024904NINDS NIH HHS R01 NS100366NINDS NIH HHS RF1 NS110049
6 · The paper itself

Abstract

Biomarkers sensitive to prodromal or early pathophysiological changes in Alzheimer's disease (AD) symptoms could improve disease detection and enable timely interventions. Changes in brain hemodynamics may be associated with the main clinical AD symptoms. To test this possibility, we measured the variability of blood oxygen level-dependent (BOLD) signal in individuals from three independent datasets (totaling 80 AD patients and 90 controls). We detected a replicable increase in brain BOLD signal variability in the AD populations, which constituted a robust biomarker for clearly differentiating AD cases from controls. Fast BOLD scans showed that the elevated BOLD signal variability in AD arises mainly from cardiovascular brain pulsations. Manifesting in abnormal cerebral perfusion and cerebrospinal fluid convection, present observation presents a mechanism explaining earlier observations of impaired glymphatic clearance associated with AD in humans.

Indexed as

AgedAlzheimer DiseaseBlood PressureBrainCerebrovascular CirculationFemaleHeart RateHemodynamicsHumansMagnetic Resonance ImagingMaleMiddle AgedRespiratory Rate

Identifiers

PMID33298996
PMCPMC7726142
OpenAlexW3111827674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.